Supplement — editorial review
Glucosamine
Editorial page for the supplement Glucosamine.
- Type
- Supplement
- Reviewed by
- —
- Last reviewed
- 2025-09
- Next review
- 2026-09
This page is part of the Osteoarthritis Observatory and covers glucosamine.
Final content will separate what is demonstrated, what is likely, and what is unknown, with verifiable references and medical review.
Until then, this architecture allows verification of editorial structure, metadata, and internal linking between related concepts.
Magnitude
Small to moderate effect size in some subgroups; not consistent across trials.
Safety
Generally favourable short-term profile; specific interactions pending review.
InteractionsPossible interactions with anticoagulants and other chronic treatments.
Regulation
Food supplement: not equivalent to an authorised medicinal product.
Limitations
Methodological heterogeneity and documented publication bias.
FundingSome trials have been industry-funded; consider conflicts of interest.
Editorial conclusion
Does not replace interventions with stronger evidence (exercise, weight control).